Scleroderma Support Group Tri Cities WA

Scleroderma Support Group Tri Cities WA We are an autoimmune support group
In Washington state

02/12/2020

CenturyLink Field Announces Transition to Cashless Operations for all Events Stadium, Event Center and WAMU Theater to Accept Credit and ...

03/21/2018

Read about a study urging caution in the use of immunosuppressive therapy for treating scleroderma-related lung disease.

02/19/2018

Farah Khaleck was just 17 when she first started experiencing the symptoms of the autoimmune disease scleroderma.

06/25/2017

What It Feels Like to Look Rare

JUNE 22, 2017

BY JESSICA MASSENGALE

IN COLUMNS, THROUGH TEAL COLORED GLASSES - A COLUMN BY JESSICA MASSENGALE.

Click Here to receive SCL News via e-mail

According to the Census Bureau, about 30 million people in the United States walk with a cane, crutch, or wheelchair. What do you do when you see someone with a visible problem? Your eyes are immediately drawn to the source, to whatever’s disturbing the “normal” flow of the human look.

The person with the “eyesore” sometimes tries to cover it up simply because they don’t want others questioning or staring. Women have the awesome chameleon capability of covering anything up with a little bit of makeup. God forbid someone see the tiny red acne on their cheeks. We have to contour our face to look flawless.

We want to keep any general problem affecting our lives hidden, especially the visible ones. Problems available for everyone to see? Who wants that? The majority of people strive to make everything seem perfect, even if their lives are in shambles. Those with a physical impairment have no choice but to show it to the world.

When I go out in public, I often get multiple eyeballs staring at me like magnets on a fridge. I know humans are curious by nature, but how uncomfortable do you think it makes me feel? At least send a smile my way when I glance back instead of looking away quickly to pretend you weren’t staring. One simple smile can really brighten up someone’s day, and in return, you’d get to see my million-dollar smile in return.

My “eyesore” is called scleroderma. My body hates itself, so for the past seven years it has been mercilessly attacking me with collagen. In this process, it has erased my beautiful caramel complexion and jaded it with large splotches of white areas, peppered with remnants of my old skin color. My fingers are so tightly packed with collagen that they’re actually frozen in place. My arms are bent at 45-degree angles, and my knees are so tight I walk with a slight limp.

I have to walk around with this 24/7. My life’s biggest problem is on display for anyone and everyone to see. It has gotten to a point where I ask strangers for help when I’m by myself. I consider it a form of bravery when one is disabled and doesn’t try to hide it. It takes in-depth mental empowerment to do this, and we all possess this confidence. We just have to harness it.

Imagine you had to walk around with an index card taped to your head that listed your biggest insecurities or problems for the entire world to see. It’s not that everyone’s opinion matters; it’s just that the visibly rare are so different-looking than the average person that you can see there’s something wrong. I have to walk around with a mental shield to pretend I don’t notice anyone staring AND at the same time keep reminding myself that I’m still pretty. Every stare I receive is like a mental bench press strengthening my mind to ignore them and carry on with my day.

It’s our turn to change society’s standards of normal.

Next time you see someone who looks sick, shoot them a smile. If you’re standing in line next to someone in a wheelchair, say “Hi!” If you see them struggling, offer help. These small gestures can close the gap between disabled and healthy. It doesn’t even have to be someone disabled; even if someone looks different than you, try your best not to make them feel different.

Having a disability makes the sick person feel rare and out-of-place in a world full of normal individuals who may never step foot in a doctor’s office. Underneath it all, we are the same as you. Our life’s story is just a little more complicated. I’m speaking for ALL of my “different-looking” family out there — in a wheelchair, toting around an oxygen tank, with a skin condition, or even missing a limb.

It’s human nature to be curious, but gawking at anyone with a rarity makes the affected person cringe on the inside. It’s like getting an extra nasty dose of a medication called reality that we really didn’t need. So, make a promise to yourself today to treat everyone you see with kindness and humility.

The power lies within you.

***

Note: Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Scleroderma News, or its parent company, BioNews Services, and are intended to spark discussion about issues pertaining to scleroderma.

06/25/2017

Scleroderma may be tough to diagnose:

Because scleroderma can take so many forms and affect so many different areas of the body, it can be difficult to diagnose.

After a thorough physical exam, your doctor may suggest blood tests to check for elevated blood levels of certain antibodies produced by the immune system. He or she may remove a small tissue sample (biopsy) of your affected skin so that it can be examined in the laboratory for abnormalities.

Your doctor may also suggest breathing tests (pulmonary function tests), a CT scan of your lungs and an echocardiogram of your heart.

06/25/2017

Noninvasive Tests Can Help to Identify Those Most Likely, or Unlikely, to Have PH

JANUARY 3, 2017

BY MAGDALENA

Noninvasive methods can help to determine which patients have a high probability of developing pulmonary hypertension (PH) and which are most unlikely to do so, researchers reported — offering clinicians further tools when examining people with suspected lung hypertension.

The study, “Use of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension,” was published in the journal PLOS ONE.

Researchers at the Medical University of Graz in Austria examined the medical records of 394 patients who had a right heart catheterization procedure (a typical diagnostic tool for PH) because of suspected PH, and discovered that right axis deviation on an electrocardiogram (ECG) predicted lung hypertension in 93 percent of them. Right axis deviation is often considered a chronic finding in patients with lung disease.

A combination of non-right axis ECG deviation, low levels of the heart disease marker NT-proBNP (N-terminal pro brain natriuretic peptide), good oxygen saturation of the blood, and WHO functional class I or II could rule out the possibility of PH with a probability of 96 percent.

To test whether the factors — retrospectively identified in the first group of patients — were truly valid predictors of the disease, the research team investigated them prospectively in another group of 168 patients. These patients underwent right heart catheterization because they were either experiencing unexplained shortness of breath or were at risk of developing PH because of an underlying disease.

An ECG showed right axis deviation in 39 of these patients, 36 of whom were later diagnosed with PH. This gave a positive predictive value of 92 percent. Among the remaining 129 patients, the absence of PH was predicted in 38 people. This turned out to be wrong only in one case, for a 97 percent probability of being right.

During the study, 151 patients had at least two right heart catheterizations, making it possible to correlate changes in ECG to changes in pulmonary artery pressure. The team found a moderate correlation between the ECG axis and the mean pulmonary arterial pressure. Levels of NT-proBNP and lung artery blood pressure also were linked.

A definitive diagnosis of PH is dependent on the invasive right heart catheterization procedure, so physicians are always looking for noninvasive ways to improve the process of reaching a diagnosis.

“Our suggested two-step algorithm recognizes patients with either a very high or a very low probability for pulmonary hypertension in nearly half of the patients at risk for PH. This result can be achieved by the systematic use of four simple, non-invasive parameters: right axis deviation in ECG, SO2 (arterial oxygen saturation), NT-proBNP and WHO functional class,” the researchers concluded. “We believe that our results may be useful for guiding the decisions towards specific diagnostics in individual patients at risk for pulmonary hypertension.”

06/25/2017

NIH RESEARCH MATTERS

March 7, 2017

New activity for anti-inflammatory drugs

At a GlanceResearchers uncovered a previously unknown pathway of activity for NSAIDs (non-steroidal anti-inflammatory drugs).The findings could be used to expand uses for NSAIDs or design next-generation therapies.

The mechanisms by which NSAIDs relieve inflammation are more complex than once thought.Nikesidoroff/iStock/Thinkstock

Scientists sometimes find novel uses for old drugs. For example, the common pain reliever aspirin is now used by millions of people to help prevent heart attack, stroke, or certain cancers. Aspirin is a type of non-steroidal anti-inflammatory drug (NSAID). Because aspirin has found multiple uses, other NSAIDs might also have health benefits that haven’t yet been discovered.

Inflammation is the body’s normal reaction to injury or disease. The result is redness, swelling, pain, and warmth in the inflamed area of the body. Although the inflammatory response enables the body to heal after injury, long-term inflammation has been linked to the development of cancer and other diseases. The sudden widespread and exaggerated inflammation in sepsis can result in tissue damage, organ failure, and even death.

Previous research has revealed some of the molecular mechanisms involved in inflammation. Aspirin and other NSAIDs are known to have anti-inflammatory effects by inhibiting COX (cyclooxygenase) enzymes. These enzymes are pivotal in the inflammatory process.

A research team led by Dr. Hang Hubert Yin of the University of Colorado, Boulder, and the BioFrontiers Institute used high-throughput screening to test nearly 1,300 FDA-approved drugs for anti-inflammatory activity. The team focused on another group of enzymes called caspases that are known to be important for inflammation and thus might also serve as useful therapeutic targets. The work was funded by NIH’s National Institute of General Medical Sciences (NIGMS). Results appeared in Cell Chemical Biology on February 23, 2017.

The team first ranked the drugs by their ability to inhibit the activity of the caspase-4 enzyme. They found 27 compounds that inhibited caspase-4 activity to less than 25%. Of these, about half—and 8 of the top 10 most potent—were NSAIDs. Further tests of 9 selected NSAIDs showed that all except aspirin inhibited multiple caspases.

In human cells, the caspases were inhibited by the same NSAIDs in the same rank order as in the high-throughput screen. Fenbufen and indoprofen were the strongest inhibitors; naproxen and ibuprofen were weak inhibitors; and aspirin was ineffective. In additional experiments, the team found that the NSAID inhibition of caspase was independent of COX enzymes.

“NSAIDs like ibuprofen and aspirin are among the most prevalent pharmaceuticals worldwide, with over 30 billion doses taken annually in the United States alone. But their precise mechanisms of action are not entirely understood,” Yin says. “We provide the first evidence for a novel mechanism of action for NSAIDs.”

Caspases are known to play a role in inflammatory diseases such as rheumatoid arthritis and heart disease. This newly discovered mechanism of NSAID activity suggests future studies into how these drugs affect caspases in the human body. The results could inform strategies to fight inflammation with fewer side effects.

—by Geri Piazza

Related LinksDrug Might Help Treat SepsisAspirin May Reduce Ovarian Cancer RiskAspirin to Reduce Cancer RiskChronic Inflammation

References: Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors. Smith CE, Soti S, Jones TA, Nakagawa A, Xue D, Yin H. Cell Chem Biol. 2017 Feb 15. pii: S2451-9456(17)30033-8. doi: 10.1016/j.chembiol.2017.02.003. [Epub ahead of print]. PMID: 28238723.

Funding: NIH’s National Institute of General Medical Sciences (NIGMS).

Search NIH Research Matters

Search NIH Research Matters' stories

In this Edition

Preventing alcohol use among American Indian and rural youth

Noninvasive strategies for lung cancer testing

New activity for anti-inflammatory drugs

Connect with Us

Subscribe to get NIH Research Matters by email

RSS FeedFacebook(link is external)Email us(link sends e-mail)

Mailing Address:
NIH Research Matters
Bldg. 31, Rm. 5B52, MSC 2094
Bethesda, MD 20892-2094

Popular Stories

How diet may affect age-related macular degeneration

A noninvasive deep brain stimulation technique

Fungi in the gut linked to alcoholic liver disease

Enzyme drives middle-age weight and fitness changes

New brain network identified for social interactions

About NIH Research Matters

Editor: Harrison Wein, Ph.D. Assistant Editors: Tianna Hicklin, Ph.D., Geriann Piazza

NIH Research Matters is a weekly update of NIH research highlights reviewed by NIH’s experts. It is published by the Office of Communications and Public Liaison in the NIH Office of the Director.

ISSN 2375-9593

Connect with UsContact UsBookmark & ShareEmail UpdatesSocial Media & OutreachTwitterFacebookYouTube

FooterNIH HomeEn EspañolSite MapVisitor InformationFrequently Asked QuestionsWeb Policies and NoticesFreedom of Information ActNo Fear ActOffice of Inspector GeneralUSA.gov – Government Made Easy

NIH…Turning Discovery Into Health®

National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892

U.S. Department of Health and Human Services(link is external)

Address

Kennewick, WA
99336

Telephone

+15096275102

Website

Alerts

Be the first to know and let us send you an email when Scleroderma Support Group Tri Cities WA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Scleroderma Support Group Tri Cities WA:

Share